Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Humana Partners Einstein Healthcare For Value-Based Care

By Zacks Investment ResearchStock MarketsDec 03, 2017 09:20PM ET
www.investing.com/analysis/humana-partners-einstein-healthcare-for-valuebased-care-200270213
Humana Partners Einstein Healthcare For Value-Based Care
By Zacks Investment Research   |  Dec 03, 2017 09:20PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
HUM
+3.43%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GTS
+0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CNC
-0.05%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
JYNT
-0.35%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Humana Inc. (NYSE:HUM) recently entered in to a value-based agreement with Einstein Healthcare Network. Per the agreement, both the companies would join forces to offer improved services to Humana’s Medicare Advantage (MA) members.

Value-based care has gained prominence in recent years in the healthcare industry. Health insurers have been forming strategic alliances for adopting this model that aims at providing coordinated, accessible, affordable and personalized health care to patients.

The deal, which extends the existing network contract between both the companies, would continue to provide access to Einstein Healthcare’s wide range of health care services to Humana’s MA members. The agreement also combines Humana with Einstein Healthcare’s Accountable Care Organization, Einstein Care Partners, in order to improve patients’ healthcare experience and outcomes in the Philadelphia area.

Humana’s wide presence of value-based care with more than 900 value-based relationships across 43 states and Puerto Rico impresses. The company had 1.9 million individual MA members as of Sep 30, 2017 along with 149,000 commercial members covered by 51,500 primary care providers.

Moreover, this new partnership will allow Humana’s MA members to spend more personal time with health professionals and enjoy personalized care customized for each person’s unique health situation. It would also provide Humana’s MA members access to proactive health screenings and programs focused on preventing illness. This value-based model would also offer better health solutions for people living with chronic conditions so that they can avoid health complications in an easier way.

The partnership would also build on updated technologies such as data analytics that would better connect physicians so that the coordinated effort can ensure better health outcomes for the patients. Moreover, the fee-for-service payment method for the physicians that considers the quality of the services being provided instead of the quantity, will also ensure better results.

This value-based care program aligns well with Einstein Healthcare’s mission to improve population health outcomes and reduce health disparities. It has a vision of providing high-quality and low-cost health care to the communities they serve.

Humana’s shares have gained 26.7% year to date, underperforming the industry’s rally of 44.1%. However, the company’s strategic alliances and strong fundamentals are likely to favor the stock going forward.

Zacks Rank & Other Stocks to Consider

Humana sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Investors interested in the same space can also consider some other stocks like Triple-S Management Corporation (NYSE:GTS) , Centene Corporation (NYSE:CNC) and The Joint Corp. (NASDAQ:JYNT) . While Triple-S Management sports a Zacks Rank #1, the other two stocks carry a Zacks Rank #2 (Buy).

Triple-S Management delivered positive surprises in two of the last four quarters, with an average beat of 74%. The stock has gained 34.8%, slightly outpacing the industry.

Centene delivered positive surprises in all of the last four quarters with an average beat of 10.6%. Its shares have returned 66.2% year to date, beating the industry mark.

Joint Corp delivered positive surprises in three of the last four quarters, with an average beat of 5.5%. Its shares have rallied 102.6% year to date, outperforming the industry.

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Click here for Zacks' private trades >>



Humana Inc. (HUM): Free Stock Analysis Report

Triple-S Management Corporation (GTS): Free Stock Analysis Report

The Joint Corp. (JYNT): Free Stock Analysis Report

Centene Corporation (CNC): Free Stock Analysis Report

Original post

Zacks Investment Research

Humana Partners Einstein Healthcare For Value-Based Care
 

Related Articles

Humana Partners Einstein Healthcare For Value-Based Care

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email